Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry corresponds to a non-coding antisense RNA transcript located antisense to the KIAA0825 gene region. There is no evidence that it encodes a protein. Antisense transcripts can sometimes regulate the expression of their sense counterparts (in this case, the protein-coding KIAA0825), but no specific functional, therapeutic, or disease-modulating activity is established for this transcript. Its biological significance, if any, would be through potential RNA-RNA or RNA-protein interactions, but these have not been characterized. The nomenclature LOC105379087 is an automated designation and does not correspond to a known, well-characterized gene product. KIAA0825, the sense gene, is a protein-coding gene linked to limb development and possibly diabetes and polydactyly phenotypes. However, antisense transcripts such as ENSG00000286577 are catalogued as non-coding and not recognized as direct therapeutic or diagnostic targets. Multiple public databases (e.g., Open Targets, E2G, Ensembl) classify ENSG00000286577 as an "intron variant, non coding transcript variant" in relation to KIAA0825.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, antisense to KIAA0825 (ENSG00000286577).